Skip to main content
Loading...
Menu top
Help
User account menu
Log in
Main navigation
Programme
Posters
Industry Symposia
Membership
Mobile Application
Menu
Login
Close
Main navigation mobile
Programme
Posters
Industry Symposia
Membership
Mobile Application
Back
43 résultats
Grid
List
Clinical and dosimetric predictors of primary hypothyroidism in nasopharyngeal carcinoma patients following intensity-modulated radiotherapy
Weekly vs 3-weekly cisplatin: a retrospective cohort study
Evaluating predictive factors for chemoradiotherapy related dysphagia in patients with head and neck cancer.
weight loss during chemoradiotherapy in patients with nasopharyngeal cancers
Cisplatin Head & Neck Chemoradiotherapy: A Real-World Survival & Compliance Analysis of Weekly vs 3-Weekly Regimes
Acute swallowing outcomes in oropharyngeal cancers following clinical introduction of dysphagia-optimised IMRT (DO-IMRT) at a single tertiary centre
Risk of Depression in tongue cancer patients as Per Hospital Anxiety and Depression Scale
Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for nasopharyngeal carcinoma
Treatment induced lymphedema in oral cancer patients: A wolf in sheep’s clothing.
Functional outcome after Locally Advanced Tongue cancer resections by Pull-through approach: Study from a tertiary cancer care center.
How applicable are the results of the DARS trial to current practice? A comparison of average dose to the pharyngeal constrictor muscles.
Selected inoperable oral cavity cancers may be salvaged using definitive radiotherapy (RT) and chemo-radiotherapy (CRT): A single center experience.
Survival Analysis of Localized Subglottic Squamous Cell Carcinoma: Therapeutic Options and Outcomes
Impact of Therapeutic Options on Survival Rates in Localized Supraglottic Squamous Cell Carcinoma
Prevalence of depression among patients with Head and Neck cancer
head and neck rhabdomyosarcoma; clinicopathological features, trends, and role of adjuvant therapy.
Induction TPF chemotherapy and its outcomes in head and neck cancer, a single centre experience
Hypofractionated radiotherapy to the larynx is effective and well tolerated in T1 glottic larynx carcinoma
The real world outcome of non-HPV head and neck cancer patients treated with definitive radiotherapy at a tertiary centre
Patient-oriented, individualized follow-up in head and neck cancer (DeIntensiF randomized trial NCT05388136)
Pagination
Previous page
‹‹
Page 2
Next page
››